Traumatic stress: Prevalence and Intervention in Groups Exposed to Critical Incidents

Not Applicable

• Conditions: Acute stress reaction; F43.1; F41.0; F43.0; Panic disorder; Post-traumatic stress disorder; Depressive episodes

• Registration Number: RBR-9z95r5
• Lead Sponsor: Programa de Pós-Graduação em Psicologia da Universidade Federal de Santa Catarina

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-06-04
• Last Update Posted: 29 May 2023

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: Not specified
• Target Recruitment: Not specified

Inclusion Criteria

Volunteers belonging to a group exposed to critical incidents; 18 year or above; clinical or subclinical level of posttraumatic stress disorder

Exclusion Criteria

Volunteers who have suffered multiple-incident childhood trauma; volunteers who have previously been diagnosed with mental disorders other than posttraumatic stress disorder, acute stress disorder, or depression- or anxiety-related disorders; volunteers who have received medical, psychiatric or psychological treatment for traumatic stress disorders, depression or anxiety in the year preceding the trail; volunteers who are presently receiving medical, psychiatric or psychological treatment for mental disorders

Study & Design

• Study Type: Intervention
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Significant reduction in PTSD-symptoms based on the diagnostic criteria B-E for PTSD in DSM-5.<br>Diagnostic test used: Clinician-Administered PTSD Scale for DSM-5. Administered 1-7 days before start of the treatment and 1-7 days after the final treatment session.<br>Self-report measure used: PTSD Checklist for DSM-5. Administered 1-7 days before start of the treatment and 1-7 days after the final treatment session.<br>Reduction of mean pre- and post treatment scores by at least 2SD<br>;Significant increase in heart-rate variability (HRV) - measured via ECG 1-7 days before start of the treatment and 1-7 days after the final treatment session<br>

Secondary Outcome Measures

Name	Time	Method
Reduction in blood pressure, measured 1-7 days before start of the treatment and 1-7 days after the final treatment session